|
125
|
413
|
6pp2A |
Structure of human endothelial nitric oxide synthase heme domain in complex with 4-((4-(2-amino-4-methylquinolin-7-yl)-2-(aminomethyl)phenoxy)methyl)benzonitrile |
|
120
|
413
|
6pp3A |
Structure of human endothelial nitric oxide synthase heme domain in complex with 7-(3-(aminomethyl)-4-(pyridin-2-ylmethoxy)phenyl)-4-methylquinolin-2-amine |
|
131
|
413
|
6pp1A |
Structure of human endothelial nitric oxide synthase heme domain in complex with 7-(3-(aminomethyl)-4-(cyclopropylmethoxy)phenyl)-4-methylquinolin-2-amine |
|
132
|
421
|
6pnbA |
Structure of human neuronal nitric oxide synthase r354a/g357d mutant heme domain in complex with 7-(4-(aminomethyl)phenyl)-4-methylquinolin-2-amine |
|
121
|
413
|
6pp4A |
Structure of human endothelial nitric oxide synthase heme domain in complex with 7-(3-(aminomethyl)-4-(pyridin-3-ylmethoxy)phenyl)-4-methylquinolin-2-amine |
|
128
|
418
|
6pn4A |
Structure of rat neuronal nitric oxide synthase heme domain in complex with 7-(3-(aminomethyl)-4-(cyclopropylmethoxy)phenyl)-4-methylquinolin-2-amine |
|
126
|
420
|
6pngA |
Structure of human neuronal nitric oxide synthase r354a/g357d mutant heme domain in complex with 7-(3-(aminomethyl)-4-propoxyphenyl)-4-methylquinolin-2-amine |
|
119
|
413
|
6poyA |
Structure of human endothelial nitric oxide synthase heme domain in complex with 7-(3-(aminomethyl)-4-propoxyphenyl)-4-methylquinolin-2-amine |
|
127
|
414
|
6pp0A |
Structure of human endothelial nitric oxide synthase heme domain in complex with 7-(3-(aminomethyl)-4-(cyclobutylmethoxy)phenyl)-4-methylquinolin-2-amine |
|
134
|
421
|
6pnaA |
Structure of human neuronal nitric oxide synthase r354a/g357d mutant heme domain in complex with 7-(4-(2-aminoethyl)phenyl)-4-methylquinolin-2-amine |
|
125
|
413
|
6poxA |
Structure of human endothelialnitric oxide synthase heme domain in complex with 7-(3-(aminomethyl)-4-ethoxyphenyl)-4-methylquinolin-2-amine |
|
120
|
413
|
6powA |
Structure of human endotheial nitric oxide synthase heme domain in complex with 7-(5-(aminomethyl)pyridin-3-yl)-4-methylquinolin-2-amine |
|
127
|
420
|
6pnhA |
Structure of human neuronal nitric oxide synthase r354a/g357d mutant heme domain in complex with 7-(3-(aminomethyl)-4-isopropoxyphenyl)-4-methylquinolin-2-amine |
|
131
|
421
|
6pnfA |
Structure of human neuronal nitric oxide synthase r354a/g357d mutant heme domain in complex with 7-(3-(aminomethyl)-4-ethoxyphenyl)-4-methylquinolin-2-amine |
|
129
|
413
|
6povA |
Structure of human endothelial nitric oxide synthase heme domain in complex with 7-(3-(2-aminoethyl)phenyl)-4-methylquinolin-2-amine |
|
132
|
418
|
6pn3A |
Structure of rat neuronal nitric oxide synthase heme domain in complex with 7-(3-(aminomethyl)-4-(cyclobutylmethoxy)phenyl)-4-methylquinolin-2-amine |
|
128
|
418
|
6pn9A |
Structure of rat neuronal nitric oxide synthase heme domain in complex with 7-(3-(aminomethyl)-4-(thiazol-5-ylmethoxy)phenyl)-4-methylquinolin-2-amine |
|
134
|
421
|
6pncA |
Structure of human neuronal nitric oxide synthase r354a/g357d mutant heme domain in complex with 7-(3-(2-aminoethyl)phenyl)-4-methylquinolin-2-amine |
|
128
|
418
|
6pn7A |
Structure of rat neuronal nitric oxide synthase heme domain in complex with 7-(3-(aminomethyl)-4-(thiazol-4-ylmethoxy)phenyl)-4-methylquinolin-2-amine |
|
125
|
418
|
6pn8A |
Structure of rat neuronal nitric oxide synthase heme domain in complex with 7-(3-(aminomethyl)-4-(oxazol-4-ylmethoxy)phenyl)-4-methylquinolin-2-amine |
|
125
|
421
|
6pndA |
Structure of human neuronal nitric oxide synthase r354a/g357d mutant heme domain in complex with 7-(3-(2-aminoethyl)phenyl)-4-methylquinolin-2-amine |
|
118
|
413
|
6pozA |
Structure of human endothelial nitric oxide synthase heme domain in complex with 7-(3-(aminomethyl)-4-isopropoxyphenyl)-4-methylquinolin-2-amine |
|
128
|
413
|
6pouA |
Structure of human endothelial nitric oxide synthase heme domain in complex with 7-(4-(2-aminoethyl)phenyl)-4-methylquinolin-2-amine |
|
125
|
418
|
6pn6A |
Structure of rat neuronal nitric oxide synthase heme domain in complex with 7-(3-(aminomethyl)-4-(pyridin-3-ylmethoxy)phenyl)-4-methylquinolin-2-amine |
|
129
|
421
|
6potA |
Structure of human neuronal nitric oxide synthase r354a/g357d mutant heme domain in complex with 7-(3-(aminomethyl)-4-(thiazol-5-ylmethoxy)phenyl)-4-methylquinolin-2-amine |
|
128
|
418
|
6pmzA |
Structure of rat neuronal nitric oxide synthase heme domain in complex with 7-(5-(aminomethyl)pyridin-3-yl)-4-methylquinolin-2-amine |
|
136
|
389
|
6kpsA |
Crystal structure of indoleamine 2,3-dioxygenagse 1 (ido1) in complex with compound 36 |
|
134
|
390
|
6kofA |
Crystal structure of indoleamine 2,3-dioxygenagse 1 (ido1) in complex with compound 47 |
|
162
|
415
|
6u4jA |
Crystal structure of idh1 r132h mutant in complex with ft-2102 |
|
193
|
552
|
6v3rA |
Crystal structure of murine cycloxygenase in complex with a harmaline analog, 4,9-dihydro-3h-pyrido[3,4-b]indole |
|
65
|
188
|
6pohA |
Crystal structure of ecdsba in complex alkyl ether 21 |
|
66
|
188
|
6poiA |
Crystal structure of ecdsba in complex phenyl ether 25 |
|
64
|
188
|
6pmlA |
Crystal structure of ecdsba in complex benzyl ether 23 |
|
64
|
188
|
6poqA |
Crystal structure of ecdsba in complex with anisidine 16 |
|
63
|
188
|
6pmfA |
Crystal structure of ecdsba in complex with aniline 15 |
|
135
|
393
|
6o3iA |
Crystal structure of human ido1 bound to navoximod (nlg-919) |
|
40
|
154
|
6a9oA |
Rational discovery of a sod1 tryptophan oxidation inhibitor with therapeutic potential for amyotrophic lateral sclerosis |
|
100
|
303
|
6plgA |
Crystal structure of human phgdh complexed with compound 15 |
|
107
|
305
|
6plfA |
Crystal structure of human phgdh complexed with compound 1 |
|
88
|
316
|
6dq5A |
Linked kdm5a jmj domain bound to the inhibitor n43 i.e. 3-((6-(4-acryloyl-1,4-diazepan-1-yl)-2-(pyridin-2-yl)pyrimidin-4-yl)amino)propanoic acid |
|
94
|
317
|
6dq6A |
Linked kdm5a jmj domain bound to the inhibitor n44 i.e. 3-((2-(pyridin-2-yl)-6-(4-(vinylsulfonyl)-1,4-diazepan-1-yl)pyrimidin-4-yl)amino)propanoic acid |
|
87
|
318
|
6dq8A |
Linked kdm5a jmj domain bound to the inhibitor n49 i.e. 2-((2-chlorophenyl)(2-(1-methylpyrrolidin-2-yl)ethoxy)methyl)thieno[3,2-b]pyridine-7-carboxylic acid |
|
92
|
318
|
6dq4A |
Linked kdm5a jmj domain bound to the inhibitor gsk-j1 |
|
87
|
318
|
6dq9A |
Linked kdm5a jmj domain bound to the covalent inhibitor n69 i.e. [2-((3-acrylamidophenyl)(2-(piperidin-1-yl)ethoxy)methyl)thieno[3,2-b]pyridine-7-carboxylic acid] |
|
87
|
318
|
6dqaA |
Linked kdm5a jmj domain bound to inhibitor n70 i.e.[2-((3-aminophenyl)(2-(piperidin-1-yl)ethoxy)methyl)thieno[3,2-b]pyridine-7-carboxylic acid] |
|
86
|
318
|
6dqbA |
Linked kdm5a jmj domain forming covalent bond to inhibitor n71 i.e. 2-((3-(4-(dimethylamino)but-2-enamido)phenyl)(2-(piperidin-1-yl)ethoxy)methyl)thieno[3,2-b]pyridine-7-carboxylic acid |
|
118
|
331
|
6badA |
Lactate dehydrogenase in complex with inhibitor (r)-3-((2-chlorophenyl)thio)-6-(3-((4-fluorophenyl)amino)phenyl)-4-hydroxy-6-(thiophen-3-yl)-5,6-dihydro-2h-pyran-2-one |
|
118
|
331
|
6bb2A |
Lactate dehydrogenase in complex with inhibitor (s)-5-((2-chlorophenyl)thio)-6'-(4-fluorophenoxy)-4-hydroxy-2-(thiophen-3-yl)-2,3-dihydro-[2,2'-bipyridin]-6(1h)-one |
|
194
|
552
|
6bl3A |
Crystal complex of cyclooxygenase-2 with indomethacin-butyldiamine-dansyl conjugate |
|
203
|
552
|
6bl4A |
Crystal complex of cyclooxygenase-2 with indomethacin-ethylenediamine-dansyl conjugate |
